Related Experiment Video
Updated: Jan 11, 2026
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
1.4K
Dendritic Cells at the Center of Reactive Tumor Immunity
Lomax Pass1,2, Matthew F Krummel1,2
1Department of Pathology, University of California, San Francisco, San Francisco, California, USA.
Immunological Reviews
|November 17, 2025
Summary
Tumor elimination relies on T cells, with dendritic cells (DCs) being crucial. Understanding DC heterogeneity and interactions advances immunotherapies and anti-tumor vaccine development.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Tumor elimination is T cell-dependent, requiring activation signals.
- Dendritic cells (DCs) are key players in tumor-reactive immunity and immunotherapy success.
- Recent research highlights DC heterogeneity and their interactions with other cells within tumors.
Purpose of the Study:
- To review the current understanding of intratumoral dendritic cell biology.
- To discuss recent advances in dendritic cell research in the context of cancer immunity.
- To explore future directions for augmenting anti-tumor immune responses via DCs.
Main Methods:
- Literature review of recent scientific publications.
- Synthesis of findings on dendritic cell heterogeneity and function.
- Analysis of cellular interactions influencing anti-tumor immunity.
Main Results:
- Dendritic cells exhibit significant heterogeneity within tumors, with specialized roles.
- A complex network of cellular interactions influences DC function and anti-tumor immunity.
- Understanding these dynamics enables novel therapeutic strategies.
Conclusions:
- Advances in understanding intratumoral DC biology are crucial for cancer immunotherapy.
- Engineering dendritic cell vaccines and other approaches can generate de novo anti-tumor immunity.
- Future research should focus on harnessing DC networks for enhanced cancer treatment.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
01:22T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
01:40Cell-mediated Immune Responses
83.4K
Overview
83.4K
01:22Antigen Presenting Cells
2.9K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
2.9K